1825 / 1851
Combined modality mainly studied in:
•brain metastases
•or recurrent glioblastoma
Less data is available for extra-cranial SRT.
SBRT and drugs
Kroeze S et al. Cancer Treatment Reviews 53 (2017) 25–37
|
|
1825 / 1851
Combined modality mainly studied in:
•brain metastases
•or recurrent glioblastoma
Less data is available for extra-cranial SRT.
SBRT and drugs
Kroeze S et al. Cancer Treatment Reviews 53 (2017) 25–37